Advertisement
Screener

DELCATH SYSTEMS, INC. (DCTH) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

DELCATH SYSTEMS, INC. Stock-Based Compensation

DELCATH SYSTEMS, INC. (DCTH) reported Stock-Based Compensation of $5.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06

  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $5.12M, a 29.01% decline year-over-year.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $4.95M, a 27.93% decline year-over-year.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.51M, a 179.90% increase year-over-year.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.65M, a 163.80% increase year-over-year.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for fiscal 2025 was $24.23M, a 148.10% increase from fiscal 2024.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for fiscal 2024 was $9.77M, a 19.83% increase from fiscal 2023.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for fiscal 2023 was $8.15M, a 2.64% increase from fiscal 2022.
  • DELCATH SYSTEMS, INC. share-based payment arrangement, expense for fiscal 2022 was $7.94M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2026-06-30$5.12M
10-Q · filed 2026-08-06
$10.06M
10-Q · filed 2026-08-06
$14.58M
derived: sum of 3 quarters · filed 2026-08-06
$20.22M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$4.95M
10-Q · filed 2026-05-07
$9.46M
derived: sum of 2 quarters · filed 2026-05-07
$15.11M
derived: sum of 3 quarters · filed 2026-05-07
$22.32M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$4.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$10.16M
derived: sum of 2 quarters · filed 2026-02-26
$17.37M
derived: sum of 3 quarters · filed 2026-08-06
$24.23M
10-K · filed 2026-02-26
2025-09-30$5.65M
10-Q · filed 2025-11-04
$12.86M
derived: sum of 2 quarters · filed 2026-08-06
$19.72M
10-Q · filed 2025-11-04
$21.33M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$7.21M
10-Q · filed 2026-08-06
$14.07M
10-Q · filed 2026-08-06
$15.68M
derived: sum of 3 quarters · filed 2026-08-06
$17.82M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$6.86M
10-Q · filed 2026-05-07
$8.47M
derived: sum of 2 quarters · filed 2026-05-07
$10.62M
derived: sum of 3 quarters · filed 2026-05-07
$13.69M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.75M
derived: sum of 2 quarters · filed 2026-02-26
$6.82M
derived: sum of 3 quarters · filed 2026-02-26
$9.77M
10-K · filed 2026-02-26
2024-09-30$2.14M
10-Q · filed 2025-11-04
$5.21M
derived: sum of 2 quarters · filed 2025-11-04
$8.15M
10-Q · filed 2025-11-04
$10.15M
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30$3.07M
10-Q · filed 2025-08-06
$6.01M
10-Q · filed 2025-08-06
$8.01M
derived: sum of 3 quarters · filed 2025-08-06
$10.84M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$2.94M
10-Q · filed 2025-05-08
$4.94M
derived: sum of 2 quarters · filed 2025-05-08
$7.77M
derived: sum of 3 quarters · filed 2025-05-08
$9.44M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$4.83M
derived: sum of 2 quarters · filed 2025-03-06
$6.49M
derived: sum of 3 quarters · filed 2025-03-06
$8.15M
10-K · filed 2025-03-06
2023-09-30$2.83M
10-Q · filed 2024-11-08
$4.49M
derived: sum of 2 quarters · filed 2024-11-08
$6.15M
10-Q · filed 2024-11-08
$8.08M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$1.66M
10-Q · filed 2024-08-05
$3.32M
10-Q · filed 2024-08-05
$5.25M
derived: sum of 3 quarters · filed 2024-08-05
$6.87M
derived: sum of 4 quarters · filed 2024-08-05
2023-03-31$1.66M
10-Q · filed 2024-05-14
$3.59M
derived: sum of 2 quarters · filed 2024-05-14
$5.21M
derived: sum of 3 quarters · filed 2024-05-14
$7.33M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$3.55M
derived: sum of 2 quarters · filed 2024-03-26
$5.67M
derived: sum of 3 quarters · filed 2024-03-26
$7.94M
10-K · filed 2024-03-26
2022-09-30$1.63M
10-Q · filed 2023-11-13
$3.75M
derived: sum of 2 quarters · filed 2023-11-13
$6.02M
10-Q · filed 2023-11-13
2022-06-30$2.12M
10-Q · filed 2023-08-09
$4.39M
10-Q · filed 2023-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
CERUS CORP (CERS)United States$0.525B-86.40
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
CARLSMED, INC. (CARL)United States$0.405B